ICIG acquires Sandoz site, expands CordenPharma’s operations
International Chemical Investors Group (ICIG) and Novartis Group have entered into an agreement in which ICIG will acquire all shares in Sandoz Industrial Products GmbH.
Archives for February 24, 2016
Unchained Labs continues breaking into biologics market
Unchained Labs has acquired Freeslate, a provider of high-throughput solutions for biologics formulation development and small molecule chemistry – marking the company’s 4th acquisition in 12 months.
'Sponsor an excipient' campaign launched by child formulation group
A European project aimed at improving formulations for children is seeking industry help to develop a database on excipient safety.
Recipharm to buy Mitim for $75m in latest Italian antibiotics sector investment
Recipharm will pay SEK640m ($75m) for Italian antibiotic filling specialist Mitim in a deal expected to complete later today.
Juno, Fred Hutch launch 'first of its kind' clinical trials unit
Juno Therapeutics and Fred Hutchinson Cancer Research Center (Fred Hutch) have announced the creation of a new clinical trials unit (CTU) dedicated to immuno-oncology.
India launches online import license application portal
Indian drug and API importers can apply for licenses online through a new service launched by the Central Drugs Standards Control Organisation (CDSCO).
correction
Zydus Cadila given nod to export antibiotic from US FDA warned plant
The US FDA has given approval to Zydus Cadila to market an antibiotic made from an Indian facility hit with a Warning Letter in December.
Albumedix and Thiologics team up on albumin conjugation tech
A technology collaboration with Thiologics could increase the efficiency and yield of albumin-conjugated drugs, says Novozymes spin-out Albumedix.